RCT | Evaluation of two short, standardized regimens for the treatment of rifampicin-resistant tuberculosis.

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial – The Lancet

Commentary: 

Shorter treatment effective for drug-resistant tuberculosis – University College London

Shorter Treatment Regimen for Drug-Resistant TB is More Effective – Health Policy Watch